MENU
ACLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Arcellx (ACLX) Ownership - Who owns Arcellx?
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more
Profile
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.34B
P/E Ratio
N/A
Total Cash
587.38M
Projected Growth
N/A
Total Debt
54.08M
Revenue
107.94M
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash/Share
10.69
Total Debt/Equity
N/A
Revenue/Share
2.02 USD as % of share price
Fundamentals
ACLX
Capitalization
3.34B
P/E Ratio
N/A
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash
587M
Total Cash/Share
10.69
Total Debt
54.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.02%
Revenue
108M
ROE
N/A
Book Value
455M
P/B Ratio
7.33
Cash Flow
N/A
Earnings
-2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
53K
Current Ratio
4.78
Current Revenue Per Employee
93656.45
Dividends Per Share - Security
N/A
EBITDA
-99.06M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-13.97
Shares Held By Institutions
6.13B
Shares Outstanding - Current
54.9M
Total Liabilities
257M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.850
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
800 Bridge Parkway
Phone
+1 240 327-0603
Employees
130
Web
https://www.arcellx.com